v3.26.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 31,718 $ 41,299
Restricted cash 110 110
Prepaid materials 3,013 3,081
Prepaid expenses and other current assets 1,827 1,128
Total current assets 36,668 45,618
Other assets 1,275 1,990
Total Assets 37,943 47,608
Current liabilities    
Accounts payable 2,569 4,293
Accrued expenses 2,807 1,307
Payroll liabilities 943 1,558
Other current liabilities 1,138 1,097
Total current liabilities 7,457 8,255
Total Liabilities 7,457 8,255
Commitments and contingencies (Note 12)
Stockholders' equity    
Convertible preferred stock - $0.001 par value; 10,000,000 shares authorized; 577 shares issued and outstanding as of March 31, 2026 and December 31, 2025 0 0
Common stock - $0.18 par value; 350,000,000 shares authorized; 8,611,361 shares issued and outstanding as of March 31, 2026 and December 31, 2025 1,550 1,550
Additional paid-in capital 286,562 285,840
Treasury stock, at cost; 88,003 shares of common stock at March 31, 2026 and December 31, 2025 (1,475) (1,475)
Accumulated deficit (256,151) (246,562)
Total Stockholders' Equity 30,486 39,353
Total Liabilities and Stockholders' Equity $ 37,943 $ 47,608